Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study.

ABSTRACT:

SUBMITTER: Medina-Pestana J 

PROVIDER: S-EPMC8967539 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature